121,134 GIP, another insulin secretion agonist, helps release insulin, particularly after eating, enhancing the effects of GLP-1 and thereby improving the overall therapeutic efficacy of the drug
In this scenario, preventing excess glucagon secretion helps lower blood sugar levels
These data come from Cosmos, a dataset created in collaboration with a community of Epic health systems representing more than 300 million patient records from 1,900 hospitals and more than 42,000 clinics from all 50 U.S
Theres a delicate balance between foods being used as energy sources, and foods being stored as fat for later
Many people on GLP-1 medications dont feel hungry enough to eat regular meals, making it easy to consume too little protein, fibre, or essential vitamins and minerals
In parallel, the landscape of pharmacological therapies for T2DM and (to a lesser extent) obesity has expanded in recent decades with new classes of molecules coming into the market